Your browser doesn't support javascript.
loading
ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Dumonceau, Jean-Marc; Kapral, Christine; Aabakken, Lars; Papanikolaou, Ioannis S; Tringali, Andrea; Vanbiervliet, Geoffroy; Beyna, Torsten; Dinis-Ribeiro, Mario; Hritz, Istvan; Mariani, Alberto; Paspatis, Gregorios; Radaelli, Franco; Lakhtakia, Sundeep; Veitch, Andrew M; van Hooft, Jeanin E.
Affiliation
  • Dumonceau JM; Gastroenterology Service, Hôpital Civil Marie Curie, Charleroi, Belgium.
  • Kapral C; Department of Gastroenterology and Hepatology, Ordensklinikum Barmherzige Schwestern, Linz, Austria.
  • Aabakken L; GI Endoscopy Unit, OUS, Rikshospitalet University Hospital, Oslo, Norway.
  • Papanikolaou IS; Hepatogastroenterology Unit, Second Department of Internal Medicine - Propaedeutic, Research Institute and Diabetes Center, Medical School, National and Kapodistrian University, Attikon University General Hospital, Athens, Greece.
  • Tringali A; Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Vanbiervliet G; Centre for Endoscopic Research, Therapeutics and Training (CERTT), Università Cattolica del Sacro Cuore, Rome, Italy.
  • Beyna T; Centre Hospitalier Universitaire de Nice, Pole D.A.R.E, Endoscopie Digestive, Nice, France.
  • Dinis-Ribeiro M; Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Düsseldorf, Dusseldorf, Germany.
  • Hritz I; Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal.
  • Mariani A; Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal.
  • Paspatis G; Semmelweis University, 1st Department of Surgery, Center for Therapeutic Endoscopy, Budapest, Hungary.
  • Radaelli F; Division of Pancreato-Biliary Endoscopy and Endosonography, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita Salute San Raffaele University, Milan, Italy.
  • Lakhtakia S; Gastroenterology Department, Benizelion General Hospital, Heraklion, Crete, Greece.
  • Veitch AM; Gastroenterology Department, Valduce Hospital, Como, Italy.
  • van Hooft JE; Asian Institute of Gastroenterology, Hyderabad, India.
Endoscopy ; 52(2): 127-149, 2020 02.
Article in En | MEDLINE | ID: mdl-31863440
ABSTRACT
PROPHYLAXIS 1  ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before endoscopic retrograde cholangiopancreatography (ERCP) in all patients without contraindications to nonsteroidal anti-inflammatory drug administration.Strong recommendation, moderate quality evidence. 2  ESGE recommends prophylactic pancreatic stenting in selected patients at high risk for post-ERCP pancreatitis (inadvertent guidewire insertion/opacification of the pancreatic duct, double-guidewire cannulation).Strong recommendation, moderate quality evidence. 3  ESGE suggests against routine endoscopic biliary sphincterotomy before the insertion of a single plastic stent or an uncovered/partially covered self-expandable metal stent for relief of biliary obstruction.Weak recommendation, moderate quality evidence. 4  ESGE recommends against the routine use of antibiotic prophylaxis before ERCP.Strong recommendation, moderate quality evidence. 5  ESGE suggests antibiotic prophylaxis before ERCP in the case of anticipated incomplete biliary drainage, for severely immunocompromised patients, and when performing cholangioscopy.Weak recommendation, moderate quality evidence. 6  ESGE suggests tests of coagulation are not routinely required prior to ERCP for patients who are not on anticoagulants and not jaundiced.Weak recommendation, low quality evidence. TREATMENT 7  ESGE suggests against salvage pancreatic stenting in patients with post-ERCP pancreatitis.Weak recommendation, low quality evidence. 8  ESGE suggests temporary placement of a biliary fully covered self-expandable metal stent for post-sphincterotomy bleeding refractory to standard hemostatic modalities.Weak recommendation, low quality evidence. 9  ESGE suggests to evaluate patients with post-ERCP cholangitis by abdominal ultrasonography or computed tomography (CT) scan and, in the absence of improvement with conservative therapy, to consider repeat ERCP. A bile sample should be collected for microbiological examination during repeat ERCP.Weak recommendation, low quality evidence.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholangiopancreatography, Endoscopic Retrograde / Self Expandable Metallic Stents Type of study: Guideline Limits: Humans Language: En Journal: Endoscopy Year: 2020 Type: Article Affiliation country: Belgium

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholangiopancreatography, Endoscopic Retrograde / Self Expandable Metallic Stents Type of study: Guideline Limits: Humans Language: En Journal: Endoscopy Year: 2020 Type: Article Affiliation country: Belgium